Oncolytics Biotech Inc. Gains 54.1%
Thu, Dec 26, 2019 at 05:30 PM
Oncolytics Biotech Inc. (ONCY:NASDAQ) soared at $2.82, a gain of 54.1%. The stock appeared on our News Catalysts scanner on Thu 12 Dec 19 at 07:58 AM in the 'BIOTECH' category. From Wed 04 Dec 19, the stock recorded 35.71% Up Days and 33.33% Green Days
About Oncolytics Biotech Inc. (ONCY:NASDAQ)
Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
Top 10 Gainers:
- China Rapid Finance Limited (XRF:NYSE), 113.11%
- Mereo BioPharma Group plc (MREO:NASDAQ), 97.25%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 54.1%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 50%
- Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ), 47.21%
- Verona Pharma plc (VRNA:NASDAQ), 44.93%
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 43.47%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 43.23%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 37.49%
- KemPharm, Inc. (KMPH:NASDAQ), 34.79%